COVID-19 Outbreak in an Urban Hemodialysis Unit-Reference-Cited by-同舟云学术

COVID-19 Outbreak in an Urban Hemodialysis Unit

Published:2020-11 Issue:5 Volume:76 Page:690-695.e1
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Yau Kevin,Muller Matthew P.,Lin Molly,Siddiqui Naureen,Neskovic Sanja,Shokar Gagan,Fattouh Ramzi,Matukas Larissa M.,Beaubien-Souligny William,Thomas Alison,Weinstein Jordan J.,Zaltzman Jeffrey,Wald Ron

Publisher

Elsevier BV

Subject

Nephrology

Reference10 articles.

1. Mitigating risk of COVID-19 in dialysis facilities;Kliger;Clin J Am Soc Nephrol.,2020

2. Clinical characteristics of and medical interventions for COVID-19 in hemodialysis patients in Wuhan, China;Xiong;J Am Soc Nephrol.,2020

3. COVID-19 and dialysis units: what do we know now and what should we do?;Ikizler;Am J Kidney Dis,2020

4. Asymptomatic transmission, the Achilles’ heel of current strategies to control COVID-19;Gandhi;N Engl J Med,2020

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Healthcare Personnel in El Salvador Prior to Vaccination Campaigns;Infectious Disease Reports;2024-06-07

2. COVID-19 incidence and outcomes among patients with kidney replacement therapy;Kidney Research and Clinical Practice;2023-09-30

3. Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease;Nature Communications;2023-09-27

4. Omicron variant BA.1, BA.5, BQ.1.1, and XBB.1.5 Neutralizing Antibodies Following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 Bivalent Vaccination;2023-05-05

5. Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease;Kidney International;2023-04